Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Diener

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Cancer Research|October 18, 2000
Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancerJ Dannull, P A Diener, L Prikler, et al.
Scandinavian Journal of Rheumatology|April 17, 2008
Soluble tumour necrosis factor receptors sTNFR1 and sTNFR2 are produced at sites of inflammation and are markers of arthritis activity in Behçet's diseaseB Turan, K Pfister, P-A Diener, et al.
Aktuelle Urologie|October 2, 2004
[Adaptive immunotherapy of the advanced prostate cancer - cancer testis antigen (CTA) as possible target antigens]L Prikler, E Scandella, Y Men, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 24, 2010
Comparison of seminal vesicle, non-malignant and malignant prostate tissues with gene expression patterns using quantitative real-time PCRR Morant, V Vuaroqueaux, P A Diener, et al.
The Journal of Pathology|November 5, 1999
Chromosomal imbalances in small cell carcinomas of the urinary bladderL Terracciano, J Richter, L Tornillo, et al.
Biochemistry|September 24, 1999
NMR solution structure of a complex of calmodulin with a binding peptide of the Ca2+ pumpB Elshorst, M Hennig, H Försterling, et al.
The American Journal of Pathology|July 19, 2011
Relevance of periostin splice variants in renal cell carcinomaLaura Morra, Markus Rechsteiner, Silvia Casagrande, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1993
Overexpression of CD3 eta during thymic development does not alter the negative selection processR E Hussey, L K Clayton, A Diener, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Cancer Research|October 18, 2000
Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancerJ Dannull, P A Diener, L Prikler, et al.
Scandinavian Journal of Rheumatology|April 17, 2008
Soluble tumour necrosis factor receptors sTNFR1 and sTNFR2 are produced at sites of inflammation and are markers of arthritis activity in Behçet's diseaseB Turan, K Pfister, P-A Diener, et al.
Aktuelle Urologie|October 2, 2004
[Adaptive immunotherapy of the advanced prostate cancer - cancer testis antigen (CTA) as possible target antigens]L Prikler, E Scandella, Y Men, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 24, 2010
Comparison of seminal vesicle, non-malignant and malignant prostate tissues with gene expression patterns using quantitative real-time PCRR Morant, V Vuaroqueaux, P A Diener, et al.
The Journal of Pathology|November 5, 1999
Chromosomal imbalances in small cell carcinomas of the urinary bladderL Terracciano, J Richter, L Tornillo, et al.
Biochemistry|September 24, 1999
NMR solution structure of a complex of calmodulin with a binding peptide of the Ca2+ pumpB Elshorst, M Hennig, H Försterling, et al.
The American Journal of Pathology|July 19, 2011
Relevance of periostin splice variants in renal cell carcinomaLaura Morra, Markus Rechsteiner, Silvia Casagrande, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1993
Overexpression of CD3 eta during thymic development does not alter the negative selection processR E Hussey, L K Clayton, A Diener, et al.
Pageof 5